Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Holdgate, Anna ^a   Foo, A ^b  

^a LIVERPOOL HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CALCIUM CHANNEL BLOCKING AGENT; VERAPAMIL;

ACUTE HEART FAILURE; BRADYCARDIA; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DYSPNEA; HEART ARREST; HOSPITALIZATION; HOT FLUSH; HUMAN; HYPOTENSION; LENGTH OF STAY; MORTALITY; NAUSEA; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PATIENT SATISFACTION; RELAPSE; REVIEW; THORAX PAIN;

EID: 34548864979     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005154.pub2     Document Type: Review

References (36)

1. Cabrera-Sole R, Abeytua M, Lopez Bescos L, Rubio R. Paroxysmal supraventricular tachycardia: efficacy of adenosine versus verapamil. Revista Espanola de Cardiologia 1989;42(Suppl 2):19.
2. Cheng KA. A randomized, multicenter trial to compare the safety and efficacy of adenosine versus verapamil for termination of paroxysmal supraventricular tachycardia. Chinese Journal of Internal Medicine 2003;42:773-776.
3. DiMarco JP, Miles W, Akhtar M, Milstein S, Sharma AD, Platia E, et al. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. Annals of Internal Medicine 1990;113:104-110.
4. Ferreira JFM, Pamplona D, Cesar LAM, Leite PF, Sosa EA, Da Luz PL, et al. Adenosin-three phosphate compared with verapamil to treat paroxysmal supraventricular tachycardia [Estudo comparativo entre verapamil e adenosina-trifosfato no tratamento das taquicardias paroxisticas supraventriculares]. Arquivos Brasileros de Cardiologia 1996;66:55-57.
5. Gil Madre J, Lazaro Rodriguez S, Sentenac Marchan G, Sepulveda Berrocal MA, Alises Moraleda JM, Cortes Bermejo S, et al. Adenosin triphosphate in the treatment of paroxysmal supraventricular tachycardia: a comparison with verapamil [Trifosfato de adenosina en el tratamiento de la taquicardia paroxistica supraventricular: comparacion con verapamilo]. Revista Espanola de Cardiologia 1995;48:55-58.
6. Greco R, Musto B, Arienzo V, Alborino A, Garofalo S, Marsico F. Treatment of paroxysmal supraventricular tachycardia in infancy with digitalis, adenosine-5′-triphosphate and verapamil: a comparative study. Circulation 1982;66:504-508.
7. Hood MA, Smith WM. Adenosine versus verapamil in the treatment of supraventricular tachycardia: a randomized double-crossover trial. American Heart Journal 1992;123:1543-1549.
8. Kulakowski P, Karpinski G, Karczmarewicz S, Czepiel A, Makowska E, Soszynska M. Efficacy and safety of adenosine in termination of paroxysmal supraventricular tachycardia: comparison with verapamil. Kardiologia Polska 1998;49:295-303.
9. Ballo P, Bernabo D, Faraguti SA. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia. European Heart Journal 2004;25:1310-1317.
10. Belhassen B, Pelleg A. Acute management of supraventricular tachycardia: verapamil, adenosine triphosphate or adenosine?. American Journal of Cardiology 1984;54:225-227.
11. Conti Gimenez LA, Gil Madre J. Adenosine triphosphate and the treatment of paroxysmal supraventricular tachycardia: a comparison with verapamil [Trifosfato de adenosina en el tratamiento de la taquicardia paroxistica supraventricular: comparacion con verapamilo]. Revista Espanola de Cardiologia 1995;48:499-500.
12. Garratt C, Linker N, Griffith M, Ward D, Camm AJ. Comparison of adenosine and verapamil for termination of paroxysmal junctional tachycardia. American Journal of Cardiology 1989;64:1310-1316.
13. Rankin AC, McGovern BA. Adenosine or verapamil for the acute treatment of supraventricular tachycardia?. Annals of Internal Medicine 1991;114:513-515.
14. Sellers TD, Kirchhoffer JB, Modesto TA. Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias. Progress in Clinical and Biological Research 1987;230:283-299.
15. Sethi KK, Singh B, Kalra GS, Arora R, Khalilullah M. Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia. Indian Heart Journal 1994;46:141-144.
16. Trappe H-J. Acute management of supraventricular tachycardia: adenosine or ajmaline? [Akuttherapie supraventrikularer tachykardien: adenosin oder ajmalin?]. Intensivmedizin und Notfallmedizin 1997;34:452-461.
17. Turkoglu C, Firatli I, Turkoglu C, Ozturk M. Effect of adenosine in termination of induced supraventricular tachycardias and comparison with verapamil [Ekektriki stimulasyonla baslatilan paroksismal supraventrikuler tasikardilerin sonlandirilmasinda adenozinin etkisi ve verapamil ile karsilastirilmasi]. Turk Kardiyoloji Dernegi Arsivi 1996;24:452- 461.
18. American Heart Association. Management of symptomatic bradycardia and tachycardia. Circulation 2005;112(24 Suppl):IV67-IV77.
19. American Heart Association. Pediatric Advanced Life Support. Circulation 2005;112(24 Suppl):IV167-186.
20. Bolton E. Disturbances of cardiac rhythm and conduction. In: TintinalliJE, KelenGD, StapczynskiJS editor(s). Emergency Medicine - a comprehensive study guide. 5th Edition. New York: McGraw-Hill, 2000:169-78.
21. Meyer ADM. Arrhythmias. In: CameronP, JelinekG, KellyA-M, MurrayL, HeyworthJ editor(s). Textbook of adult emergency medicine. Edinburgh: Churchill Livingstone, 2000:162-4.
22. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-91.
23. Dougherty AH, Jackman WM, GV Naccarelli, Friday KJ, Dias VC. Acute conversion of paroxysmal supraventricular tachycardia. IV diltiazemstudy group. American Journal of Cardiology 1992;70:587-92.
24. Faulds D, Crisp P, Buckley MM. Adenosine. An evaluation of its use in diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia. Drugs 1991;41:596-624.
25. Gupta A, Naik A, Vora A, Lokhandwala Y. Comparison of the efficacy of diltiazemand esmolol in terminating supraventricular tachycardia. Journal of the Association of Physicians of India 1999;47:969-72.
26. Josephson ME, Zimetbaum P. The tachyarrhythmias. In: BraunwaldE, et al. editor(s). Harrisons Textbook of Internal Medicine. 15th Edition. New York: McGraw Hill, 2003.
27. Hourigan C, Safih S, Rogers I, Jacobs I, Lockney A. Randomized controlled trial of midazolam premedication to reduce the subjective adverse effects of adenosine. Emergency Medicine Australasia 2001;13:51-56.
28. Jordaens L, Gorgels, Stroobandt R, Temmerman J. Efficacy and safety of intravenous sotalol for termination of supraventricular tachycardia. The sotalol versus placebomulticenter study group. American Journal of Cardiology 1991;68:35-40.
29. Joshi PP, Deshmukh PK, Salkar RG. Efficacy of intravenous magnesium suplphate in supraventricular tachyarrhythmias. Journal of the Association of Physicians of India 1995;43:529-31.
30. Hondeghem LM, Roden DM. Agents used in cardiac arrhythmias. In: KatzungBG editor(s). Basic and Clinical Pharmacology. 6th Edition. Connecticut: Prentice-Hall International, 1995.
31. Lefebvre C, McDonald S. Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. Fourth International Cochrane Colloquium, Adelaide, Australia, 20-24 October. 1996.
32. Lim SH, Anantharaman V, Teo WS, Goh PP, Tan AT. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Annals of Emergency Medicine 1998;31:30-5.
33. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stoup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the Quorom statement. Lancet 1999;354:1896-900.
34. Ornato JP, Hallagan LF, Reese WA, Clark RF, Tayal VS, Garnett AR, et al. Treatment of paroxysmal supraventricular tachycardia in the emergency department by clinical decision analysis. American Journal of Emergency Medicine 1990;6:555-560.
35. Taylor DM, Wong LF. Incorrect instruction in the use of the Valsalva manoeuvre for paroxysmal supaventricular tachycardia is common. Emergency Medicine Australasia 2004;16:284-287.
36. Wen ZC, Chen SA, Tai CT, Chiang CE, Chiou CW, Chang MS. Electrophysiological mechanisms and determinants of vagal manouevres for termination of paroxysmal supraventricular tachycardia. Circulation 1998;98:2716-23.